Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744148 | PMC |
| http://dx.doi.org/10.1016/j.jacep.2021.09.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence.
Cancers (Basel)
May 2024
Division of Pathology, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Effective risk assessment in early breast cancer is essential for informed clinical decision-making, yet consensus on defining risk categories remains challenging. This paper explores evolving approaches in risk stratification, encompassing histopathological, immunohistochemical, and molecular biomarkers alongside cutting-edge artificial intelligence (AI) techniques. Leveraging machine learning, deep learning, and convolutional neural networks, AI is reshaping predictive algorithms for recurrence risk, thereby revolutionizing diagnostic accuracy and treatment planning.
View Article and Find Full Text PDFExploring the Intersection of Artificial Intelligence and Clinical Healthcare: A Multidisciplinary Review.
Diagnostics (Basel)
June 2023
Pharmacognosy-Phytotherapy, Grigore T. Popa University of Medicine and Pharmacy Iasi, Universitatii Street 16, 700115 Iasi, Romania.
Artificial intelligence (AI) plays a more and more important role in our everyday life due to the advantages that it brings when used, such as 24/7 availability, a very low percentage of errors, ability to provide real time insights, or performing a fast analysis. AI is increasingly being used in clinical medical and dental healthcare analyses, with valuable applications, which include disease diagnosis, risk assessment, treatment planning, and drug discovery. This paper presents a narrative literature review of AI use in healthcare from a multi-disciplinary perspective, specifically in the cardiology, allergology, endocrinology, and dental fields.
View Article and Find Full Text PDFThe authors reply.
Pediatr Crit Care Med
January 2023
Service SAMU-Urgences, Centre Hospitalier Universitaire Édouard Herriot, Hospices, Civils de Lyon, Lyon, France.
Breaking Down the Boxes-Time to Reshape Demographic Data-Reply.
JAMA Pediatr
October 2022
Division of Neonatology, Department of Pediatrics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.
An Italian Online Survey Regarding the Use of Hyaluronidase in Previously Hyaluronic Acid-Injected Noses Looking for Surgical Rhinoplasty.
Aesthet Surg J Open Forum
July 2022
Multidisciplinary Department of Medical-Surgical and Dental Specialties, Oral and Maxillofacial Surgery Unit, University of Campania "Luigi Vanvitelli", Naples, Italy.
Background: Nonsurgical nasal reshaping (nSNR) with hyaluronic acid (HA) filler is a well-established procedure performed to ameliorate nasal appearance and is considered a valid alternative to surgical rhinoplasty in selected patients.
Objectives: The aim of our study is to evaluate the decision-making process and management of patients undergoing rhinoplasty, with previous HA filler injection, and evaluate if consensus could be achieved to recommend guidelines.
Methods: Between April and May 2021, an online survey was sent to 402 Italian surgeons of different specialties.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!